ABOUT US
Matthew Johnson
Hydrogen Specialist & CEO of Axiom H2
Axiom H2 was born out of frustration—and purpose. As a lifelong health and fitness advocate with a background in holistic nutrition, strength and conditioning, supplementation, oxygen/ozone therapy, and molecular hydrogen, I found a major gap in the hydrogen therapy space: a lack of high-quality products and almost no transparency in testing.
At Axiom H2, we set out to change that.
This vision led to the creation of the HW600 Cellular Optimizer—the world’s first tested, board-certified, and doctor-endorsed hydrogen system. Crafted with medical-grade materials, it delivers hydrogen levels that surpass IHSA benchmarks and sets a new standard for safety, performance, and innovation.
At Axiom H2, we’re not just committed to results—we’re committed to creating an exceptional healing experience backed by science, trust, integrity, and exceptional customer service.

Matthew Johnson
Hydrogen Specialist & CEO of Axiom H2

Axiom H2 was born out of frustration—and purpose. As a lifelong health and fitness advocate with a background in holistic nutrition, strength and conditioning, supplementation, oxygen/ozone therapy, and molecular hydrogen, I found a major gap in the hydrogen therapy space: a lack of high-quality products and almost no transparency in testing.
At Axiom H2, we set out to change that.
This vision led to the creation of the HW600 Cellular Optimizer—the world’s first tested, board-certified, and doctor-endorsed hydrogen system. Crafted with medical-grade materials, it delivers hydrogen levels that surpass IHSA benchmarks and sets a new standard for safety, performance, and innovation.
At Axiom H2, we’re not just committed to results—we’re committed to creating an exceptional healing experience backed by science, trust, integrity, and exceptional customer service.
OUR MISSION
Revolutionizing health, recovery, & performance with the highest-quality hydrogen solutions, setting the industry standard in technology, durability, and excellence. Empowering people worldwide where modern therapies fall short.
Â